Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Clow

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
The Journal of Pharmacy and Pharmacology|January 1, 1978
A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugsP Jenner, P N Elliott, A Clow, et al.
Psychophysiology|May 23, 1998
Secretory immunoglobulin A and cardiovascular reactions to mental arithmetic and cold pressorG Willemsen, C Ring, D Carroll, et al.
Life Sciences|April 6, 1981
Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brainA Theodorou, W Gommeren, A Clow, et al.
Developmental and Comparative Immunology|July 30, 1999
Echinoderm immunity and the evolution of the complement systemP S Gross, W Z Al-Sharif, L A Clow, et al.
Biochemical Pharmacology|August 4, 1992
Inhibitory potency of some isatin analogues on human monoamine oxidase A and BA E Medvedev, B Goodwin, A Clow, et al.
Neuroscience Letters|October 28, 1991
Effect of aromatic amino acids, pentylenetetrazole and yohimbine on isatin and tribulin activity in rat brainS K Bhattacharya, A Clow, A Przyborowska, et al.
Neuroscience Letters|March 6, 1998
Regional and molecular separation of the four bioactivities of 'tribulin'F Hucklebridge, A Doyle, F Y Pang, et al.
Nature|April 8, 1982
Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatumK Murugaiah, A Theodorou, S Mann, et al.
Journal of Neural Transmission. General Section|January 1, 1991
(-)-Deprenyl can induce soluble superoxide dismutase in rat striataA Clow, T Hussain, V Glover, et al.
Psychoneuroendocrinology|August 11, 2007
Cortisol secretory activity in older people in relation to positive and negative well-beingP Evans, D Forte, C Jacobs, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Pharmacy and Pharmacology|January 1, 1978
A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugsP Jenner, P N Elliott, A Clow, et al.
Psychophysiology|May 23, 1998
Secretory immunoglobulin A and cardiovascular reactions to mental arithmetic and cold pressorG Willemsen, C Ring, D Carroll, et al.
Life Sciences|April 6, 1981
Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brainA Theodorou, W Gommeren, A Clow, et al.
Developmental and Comparative Immunology|July 30, 1999
Echinoderm immunity and the evolution of the complement systemP S Gross, W Z Al-Sharif, L A Clow, et al.
Biochemical Pharmacology|August 4, 1992
Inhibitory potency of some isatin analogues on human monoamine oxidase A and BA E Medvedev, B Goodwin, A Clow, et al.
Neuroscience Letters|October 28, 1991
Effect of aromatic amino acids, pentylenetetrazole and yohimbine on isatin and tribulin activity in rat brainS K Bhattacharya, A Clow, A Przyborowska, et al.
Neuroscience Letters|March 6, 1998
Regional and molecular separation of the four bioactivities of 'tribulin'F Hucklebridge, A Doyle, F Y Pang, et al.
Nature|April 8, 1982
Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatumK Murugaiah, A Theodorou, S Mann, et al.
Journal of Neural Transmission. General Section|January 1, 1991
(-)-Deprenyl can induce soluble superoxide dismutase in rat striataA Clow, T Hussain, V Glover, et al.
Psychoneuroendocrinology|August 11, 2007
Cortisol secretory activity in older people in relation to positive and negative well-beingP Evans, D Forte, C Jacobs, et al.
Pageof 16